argenx Logo (EUIPO, 11/25/2022)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark argenx was filed as Figurative mark on 11/25/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/04/2024.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#One circle #Other combinations of different geometrical figures, juxtaposed, joined or intersecting, combinations of more than two different geometrical figures #Other geometrical solids
| Trademark form | Figurative mark |
| File reference | 018802240 |
| Application date | November 25, 2022 |
| Publication date | April 14, 2023 |
| Entry date | April 4, 2024 |
| Expiration date | November 25, 2032 |
Trademark owner
Industriepark Zwijnaarde 7
9052 Zwijnaarde
BE
9052 Zwijnaarde
BE
Trademark representatives
Mindspace Eurotheum Neue Mainzer Straße 66-68
60311 Frankfurt
DE
Objection / Complaint
07/13/2023: Likelihood of confusion
Applicant
bioMérieux
goods and services
5
Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
35
Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; Administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs
42
Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development
44
Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; Provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 30, 2024 | Change Representative, Published |
ID: 11018802240